228 related articles for article (PubMed ID: 8433517)
1. [Hemolytic uremic syndrome (HUS): pathophysiology--with reference to the differentiation between HUS and thrombotic thrombocytopenic purpura].
Naruse T
Nihon Rinsho; 1993 Jan; 51(1):187-92. PubMed ID: 8433517
[TBL] [Abstract][Full Text] [Related]
2. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
Desch K; Motto D
J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
[TBL] [Abstract][Full Text] [Related]
3. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
Sánchez Avalos JC
Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
Kakishita E
Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
[TBL] [Abstract][Full Text] [Related]
5. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
7. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
Myers L
Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) in adult].
Horata-Takahashi E; Kamata K; Takeuchi Y; Kikawada R; Okubo M
Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):727-39. PubMed ID: 8084074
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
13. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Shah NT; Rand JH
Mt Sinai J Med; 2003 Oct; 70(5):344-51. PubMed ID: 14631521
[TBL] [Abstract][Full Text] [Related]
14. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
Fakhouri F; Frémeaux-Bacchi V
Nat Clin Pract Nephrol; 2007 Dec; 3(12):679-87. PubMed ID: 18033227
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
[TBL] [Abstract][Full Text] [Related]
17. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
18. [Pathophysiology of thrombotic microangiopathies: current understanding].
Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Mauro M; Kim J; Costello C; Laurence J
Am J Hematol; 2001 Jan; 66(1):12-22. PubMed ID: 11426486
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Elliott MA; Nichols WL
Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
